We observed a markedly reversed regulation of the core genes of this NF-κB-regulated transcriptional network in the context of COVID-19 versus low-dose IL-2 treatment in T1D (Fig. 3D). The gene discussed is NFKB1; the disease is type 1 diabetes mellitus.